Valeo Financial Advisors, LLC Immuno Gen, Inc. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$5.79 - $8.6 $694 - $1,032	-120 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$6.5 - $10.53 $780 - $1,263	120 New	120 $1,000
Q1 2019 Apr 12, 2019	SELL	$2.41 - $5.91 $115 - $283	-48 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $7,140 - $9,112	-750 Reduced 93.98%	48 $0
Q1 2018 Apr 12, 2018	BUY	$6.7 - $12.95 $5,346 - $10,334	798 New	798 $8,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.